US Patent 11787860 Anti-CD47 antibodies and uses thereof
Patent 11787860 was granted and assigned to Celgene on October, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11787860 Anti-CD47 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
